SurVac
Hellerup
About SurVac
Survac ApS focuses on the development of peptide based therapeutic cancer vaccines. It intends to offer the vaccine candidates for licensing and collaboration agreements.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Phone: +33 442 98 15 60
Canonical: https://fsome.com/organization/survac-420785 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.